GUMC Update is the electronic newsletter for the Georgetown University Medical Center community. Please let us know what you think.

To view previous issues of GUMC Update, visit the Update Archive.

Did you know you can have GUMC Update route to the Primary tab in your Gmail inbox rather than the Promotions tab? Just click, hold and drag it over to the Primary tab and Gmail will ask if you want all e-mails from GUMC Communications to go there. Click here for more helpful tips to customize your Gmail inbox tabs.


GUMC ONLINE NEWS	More online news >

Georgetown Lombardi Secures Prestigious NCI Endorsement

Georgetown Lombardi has received the federal government's most powerful endorsement for its work in cancer prevention, research and treatment with the renewal of its Cancer Center Support Grant and comprehensive status.

Katherine Conant, MD, says endowed support she received a few years ago has enabled her to gather enough data and momentum to secure federal funding. Now she is on her way to decoding a new molecular pathway underlying a variety of neurodegenerative diseases, including Alzheimer's and HIV-induced dementia.

Professor Recognized as Leader in Neurorehabilitation Research

Alexander Dromerick, MD, has been selected to receive the Outstanding Neurorehabilitation Clinician-Scientist Award from the American Society of Neurorehabilitation for his leadership in clinical research and in advancing knowledge about recovery after stroke and traumatic injury.

Fourth-year medical student Derek Rogalsky has received the American Medical Association's "Physicians of Tomorrow" Award, which recognizes high academic achievement through $10,000 scholarships.

O'Neill Institute Convenes Experts to Discuss Ebola Epidemic

At an event convened Sept. 3 by Georgetown's O'Neill Institute of National and Global Health Law, GUMC's Dan Lucey, MD, MPH, and Kevin Donovan, MD, joined a panel of experts moderated by Georgetown Law Center Professor Lawrence Gostin on the Ebola epidemic.


FEATURED VIDEO

Research & Innovation at Georgetown University
Medical Center

Research and innovation are core functions at GUMC. View an inspiring video story about lives that have been touched by groundbreaking research.

Watch video >


GUMC IN THE NEWS

The New York Times, Reuters, Associated Press (published worldwide), Bloomberg and CBS News Radio (two versions distributed nationwide) quoted Dr. Louis Weiner about the FDA's approval of a "game-changing" immunotherapy for melanoma.

The media continue to cover the worsening Ebola crisis in West Africa. C-SPAN

broadcasted a colloquium on Ebola hosted by the O'Neill Institute for National and Global Health Law featuring Dr. Kevin Donovan and Dr. Daniel Lucey. Additional coverage included USA Today and LiveScience (wire service carried by Discovery News, FoxNews, Huffington Post, etc.) in which Dr. Lucey was quoted. Other: Mr. John Kraemer was featured prominently in a Washington Post article about Ebola. NBCNews.com interviewed Dr. Lucey about the organizations involved in the Ebola fight.

The BBC quoted Dr. Jesse Goodman following his participation in a WHO meeting on potential therapies for Ebola. USA Today quote Dr. Lucey in two articles about Ebola.

The Associated Press featured Dr. Lucey in an article and video about his experience with safe practices in Sierra Leone.

The Georgetown Voice published a profile about NHS.

The UK Daily News, Genetic Engineering & Biotechnology News and Catholic Online carried a story about Dr. Jeffrey Toretsky's publication calling for an investigation into cloud-like collections in cells.

Dr. Kevin Donovan was interviewed by Medical Ethics Advisor about end-of-life care (PDF available).


PRESS RELEASES

Brain Study Shows Dyslexia Impacts Mathematical Processing

In the first known study of its kind, GUMC researchers have identified brain activity that links dyslexia to difficulty with math. The investigators say the finding has important ramifications for recognizing the wide spread repercussions of dyslexia.

Read More >

Georgetown Offers New Treatment Study for Alzheimers Disease

The Memory Disorders Program at GUMC is seeking volunteers to participate in a new treatment study for people with mild to moderate Alzheimer's disease. The study, called "NOBLE," evaluates the potential benefits of adding an investigational drug, T-817MA, to donepezil (Aricept�).

Read More >

Georgetown Lombardi Receives Renewal as DC's Only Federally Designated Comprehensive Cancer Center

Federal designation as a comprehensive cancer center indicates that Georgetown Lombardi excels in laboratory science, clinical research and population-based programs, along with robust translational research that bridges these areas.

Read More >


AROUND CAMPUS

Thompson Center Breaks Ground at Georgetown

Georgetown celebrated the groundbreaking of a new state-of-the-art athletic facility on Friday with current and former student athletes, university leaders and special guests. The facility is named for legendary Hoyas men's basketball coach John Thompson Jr., who served as head coach of Georgetown's men's basketball team from 1972-1999.

Read More >


RECENTLY ON SOCIAL MEDIA

Georgetown Lombardi Comprehensive Cancer Center

"It is a powerful endorsement ... that the work we have done and continue to do is having high impact-both locally and globally," Georgetown Lombardi Director Louis Weiner said, upon receiving the news that his center's comprehensive status and its Cancer Center Support Grant have been renewed by the National Cancer Institute. Read more: http://bit.ly/1m0qEHm

See more Georgetown Lombardi on Facebook >

@gumedcenter

#Georgetown seeks volunteers for new study of mild/moderate #Alzheimer's patients taking #donepezil. Know someone? http://bit.ly/WNG3Pd

See more GUMC on Twitter >